SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-033444
Filing Date
2023-12-04
Accepted
2023-12-04 08:00:53
Documents
15
Period of Report
2023-12-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K govx20231202_8k.htm   iXBRL 8-K 35523
2 EXHIBIT 4.1 ex_602322.htm EX-4.1 122302
3 EXHIBIT 10.1 ex_602323.htm EX-10.1 44228
  Complete submission text file 0001437749-23-033444.txt   397438

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA govx-20231202.xsd EX-101.SCH 3891
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20231202_def.xml EX-101.DEF 13826
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20231202_lab.xml EX-101.LAB 18218
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20231202_pre.xml EX-101.PRE 13858
9 EXTRACTED XBRL INSTANCE DOCUMENT govx20231202_8k_htm.xml XML 4484
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

IRS No.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39563 | Film No.: 231461345
SIC: 2834 Pharmaceutical Preparations